Faculty and Staff Stories
Brandon Hayes-Lattin, M.D.
As a cancer survivor, this OHSU oncologist is in a unique position to empathize with the young patients he treats at the Adolescent and Young Adult Oncology program at the OHSU Knight Cancer Institute.
Brian Druker, M.D.
Dr. Druker, director of the OHSU Knight Cancer Institute, says the end of cancer is within reach. In 2009 he received what's been called "America's Nobel" for his research, which led to the development of Gleevec, the first targeted cancer pill to kill cancer cells while leaving healthy tissue unharmed.
Dennis Bourdette, M.D.
Read why Dr. Bourdette, the Roy and Eulalia Swank Family Research Professor and Chairman of the Department of Neurology and director of the MS Center of Oregon at OHSU has more hope than ever for MS patients.
Sanjiv Kaul, M.D.
Dr. Kaul pioneered myocardial contrast echocardiography, or MCE, which is leading to earlier diagnoses of heart conditions. Read why tiny bubbles are the future of cardiovascular medicine and beyond.
Shoukhrat Mitalipov, Ph.D.
Shoukhrat Mitalipov, Ph.D. made international news in August, 2009, when his lab made a major breakthrough in the field of gene therapy that shows great promise in preventing certain inherited diseases.
Growing up in South Africa, Valerie had an experience that moved her to make an impact on global health disparities. As director of the interdisciplinary Community Health & Education Exchange at the OHSU Global Health Center she's doing just that.